Low dose naltrexone in refractory neuropathic pain associated with autoimmune transverse myelitis (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Low dose naltrexone in refractory neuropathic pain associated with autoimmune transverse myelitis

J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00354-5/fulltext

A case of transverse myelitis (TM) with secondary central pain syndrome refractory to multiple pain medications and immune-modulation therapies, which responded to low dose (3-4.5 mg) Naltrexone.